National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
2011/11/19 by Thomas J. Montine, Creighton H. Phelps, Thomas G. Beach +13 · 75 citations
Medicine · Neuroscience · #Dementia and Cognitive Impairment Research #Neurological Disorders and Treatments #Alzheimer's disease research and treatments
paper · doi:10.1007/s00401-011-0910-3
Citations
Cited by
- Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
- Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
- Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database
- A guide for blood–brain barrier models
- Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
- Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer’s disease
- Ambient Air Pollution and the Severity of Alzheimer Disease Neuropathology
- Molecular pathology of neurodegenerative diseases: principles and practice
- Semi-Automated Digital Image Analysis of Pick’s Disease and TDP-43 Proteinopathy
- Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
- Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging
- Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses
- The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases
- Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations
- Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)
- Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changes
- Integrated multimodal cell atlas of Alzheimer’s disease
- The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center
- Lewy body co‐pathology in Alzheimer's disease and primary age‐related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns
- X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
- Structural Similarity Networks Reveal Brain Vulnerability in Dementia
- Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age‐related tauopathy hippocampi
- Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
- Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies
- Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease
- Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
- Multiple Neuropathologies Underly Hippocampal Subfield Atrophy in a Case With a Slowly Progressive Amnestic Syndrome: Challenging the Notion of Pure LATE‐NC
- White-matter commissures: a clinically focused anatomical review
- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
- Multiple system aging‐related tau astrogliopathy with complex proteinopathy in an oligosymptomatic octogenarian
- Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
- Amygdala-predominant Lewy bodies associate with cognitive decline and amygdala atrophy in Alzheimer’s disease neuropathological change
- β-Amyloid induces microglial expression of GPC4 and APOE leading to increased neuronal tau pathology and toxicity
- Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease
- Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias
- Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease
- Automatic classification of AD pathology in FTD phenotypes using natural speech
- Celebrating 40 years of the University of Kentucky Alzheimer's Disease Research Center
- Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
- Molecular glue degraders enhance CAPRIN1-dependent lysosomal degradation of APP in Alzheimer’s disease
- Morphological and Hyperphosphorylation Transitions of Nanoscale Tau Aggregates in Alzheimer's Disease
- Distinct neuroinflammatory profiles in progressive supranuclear palsy associated with HLA haplotypes
- Expression pattern of perilipins in human brain during aging and in Alzheimer's disease
- Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's disease
- Air pollution and Alzheimer disease phenotype deplete esterified proresolving lipid mediator reserves in the brain
- Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. [europepmc]
- Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. [europepmc]
- Neuropathologic substrates of Parkinson disease dementia. [europepmc]
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. [europepmc]
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. [europepmc]
- Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. [europepmc]
- Primary age-related tauopathy (PART): a common pathology associated with human aging. [europepmc]
- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. [europepmc]
- The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. [europepmc]
- Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. [europepmc]
- Alzheimer's disease: experimental models and reality. [europepmc]
- Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football. [europepmc]
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. [europepmc]
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. [europepmc]
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. [europepmc]
- Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. [europepmc]
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. [europepmc]
- The neuropathological diagnosis of Alzheimer's disease. [europepmc]
- Molecular characterization of selectively vulnerable neurons in Alzheimer's disease. [europepmc]
- New insights into atypical Alzheimer's disease in the era of biomarkers. [europepmc]
- Alzheimer disease. [europepmc]
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. [europepmc]
- Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. [europepmc]
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. [europepmc]
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. [europepmc]